TB Research

Impact of Side Effects on Adherence in Drug-Resistance Tuberculosis Treatment at RSD dr. Soebandi Jember

Afifah Machlaurin, Neny Poerwahyuningrum, Fifteen Aprila Fajrin, Angga Mardro Rahardjo, Irma Prasetyowati, Khoiriyatul Muhlishoh Arwi

MEDFARM Jurnal Farmasi dan Kesehatan · 2025-06

Abstract

Tuberculosis (TB) is the leading cause of death from infectious disease worldwide. Patient adherence to treatment is crucial for therapy which side effects of tuberculosis treatment are a significant factor affecting compliance. This study aims to analyze the impact of side effects from anti-tuberculosis drugs on the medication adherence of Drug Resistant Tuberculosis patients (DR-TB) at RSD dr. Soebandi in Jember. The study design is a retrospective cohort observational design included 245 DR-TB patients register at the dr. Soebandi Hospital from January 2021-December 2023. Data analysis was conducted in SPSS 27.0. Ten patients, were excluded due to HIV comorbidities, resulting a final sample of 235 patients. The Proportion of Days Covered (PDC) method was used to evaluate medication adherence. The findings revealed that 53.6% of patients were non-compliant. The three most common types of side effects were gastrointestinal (43.4%), musculoskeletal (29.8%) and skin-related (16.6%). A multivariate logistic regression showed a significant relationship between the presence of side effects (aOR: 0,148; 95%CI 0,052-0,424), the number of side effects (aOR: 0,246; 95%CI 0,085-0,715), and the musculoskeletal-related side effects (aOR: 0,331; 95%CI 0,158-0,695) with patient adherence. Keywords: DR-TB, side effects, adherence, PDC method

MeSH terms

  • Medicine
  • Tuberculosis
  • Drug
  • Pharmacology
  • Drug resistance